CD8A and B-cell chronic lymphocytic leukemia: For instance, it has been reported that phosphoinositide 3-kinase (PI3K) inhibitors can downregulate the expression of exhaustion-associated genes and increase the proportion of CD8+ CAR-T cells with stem-like characteristics, ultimately enhancing their ability to eliminate chronic lymphocytic leukemia cells in vivo [45].